Iterum Therapeutics plc Ordinary Share (ITRM) is a publicly traded Healthcare sector company. As of May 21, 2026, ITRM trades at $0.03 with a market cap of $1.60M and a P/E ratio of -0.04. ITRM moved -28.57% today. Year to date, ITRM is -94.99%; over the trailing twelve months it is -97.56%. Its 52-week range spans $0.03 to $3.02. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces ITRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ITRM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $0.03 |
| Market Cap | $1.60M |
| P/E Ratio | -0.04 |
| EPS | $-0.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.02 |
| 52-Week Low | $0.03 |
| Volume | 65.74M |
| Avg Volume | 0 |
| Revenue (TTM) | $390.00K |
| Net Income | $-26.96M |
| Gross Margin | 0.00% |
1 analysts cover ITRM: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.